IL2 and neoplasm: As shown in Figures 3B and 3C, the MOSEC tumor cells treated with NKG2D-Fc-IL2 demonstrated significantly more luciferase activity in comparison to the MOSEC tumor cells treated with Con-Fc-IL2, NKG2D-Fc, or Con-Fc, or to the control (no treatment).